This proposed rule from the U.S. Food and Drug Administration would require unique identifiers on medical devices. While the rule aims to ease the collection and analysis of data about adverse health events and help detect counterfeit products, no patient information would be collected in a proposed new FDA database to help track the safety of these devices.